Osteogenic induction of menstrual blood mesenchymal stem cell by different Ferula species extracts | ||
Avicenna Journal of Phytomedicine | ||
مقاله 8، دوره 11، شماره 3، مرداد و شهریور 2021، صفحه 281-291 اصل مقاله (948.74 K) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2020.16956 | ||
نویسندگان | ||
Razieh Dalirfardouei1؛ Elahe Mahdipour* 2؛ Mehrdad Iranshahi3؛ Khadijeh Jamialahmadi* 3 | ||
1Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran | ||
2Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
3Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran | ||
چکیده | ||
Objective: Ferula spp. have many applications in complementary medicine and are recognized as the most important sources of natural products for bone health and regeneration especially in postmenopausal women. Therefore, the aim of this study was to investigate the effects of the extracts from three Ferula species on proliferation and osteogenesis potential of human menstrual blood-derived mesenchymal stem cells (MenSCs). Materials and Methods: The possible cytotoxic activity of three members of Ferula spp. (at concentrations of 5 to 100 μg/ml) was determined using MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay. Alkaline phosphatase (ALP) activity assay, Alizarin Red-S staining, and the expression analysis of an osteoblastic gene were performed to evaluate osteogenic differentiation potential. Results: The extracts of F. flabelliloba and F. szowitsiana decreased the viability and growth of MenSCs while F. foetida increased the proliferation of cells after 72 hr incubation. Treatment of MenSCs with selected plant extracts revealed that F. foetida and F. szowitsiana could enhance the osteogenic potential of MenSCs in terms of ALP activity. The Runx-2 expression in the presence of F. foetida was significantly greater than observed following treatment with 17β-estradiol (as positive control). Conclusion: The results of this study suggest that F. foetida and F. szowitsiana may have therapeutic values as a nutraceutical with respect to their considerable influence on osteogenic potential of mesenchymal stem cells. | ||
کلیدواژهها | ||
Medicinal plant؛ Ferula species؛ Osteogenic differentiation؛ ALP activity؛ Runx-2؛ Mesenchymal stem cells | ||
مراجع | ||
Akaberi M, Iranshahy M, Iranshahi M. 2015. Review of the traditional uses, phytochemistry, pharmacology and toxicology of giant fennel (Ferula communis L. subsp. communis). Iran J Basic Med Sci, 18: 1050-1062. Beral V. 2003. Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet, 362: 419-427. Brunk CF, Jones KC, James TW. 1979. Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem, 92: 497-500. Cavani F, Ferretti M, Carnevale G, Bertoni L, Zavatti M, Palumbo C. 2012. Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats. J Bone Miner Metab, 30: 619-629. Cole ZA, Dennison EM, Cooper C. 2008. Osteoporosis epidemiology update. Curr Rheumatol Rep, 10: 92-96. Collaborative Group on Epidemiological Studies of Ovarian. 2015. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet, 385: 1835-1842. Dalirfardouei R, JamialahmadiK, Mahdipour E. 2018. A feasible method for the isolation of mesenchymal stem cells from menstrual blood and their exosomes. Tissue Cell, 55: 53-62. Dalirfardouei R, Jamialahmadi K, Jafarian AH, Mahdipour E. 2019. Promising effects of exosomes isolated from menstrual bloodderived mesenchymal stem cell on woundhealing process in diabetic mouse model. J Tissue Eng Regen Med, 13: 555-568. Ducy P, Zhang R, Geoffroy V, Ridall AL,KarsentyG. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell, 89: 747-754. Ferretti M, Bertoni L, Cavani F, Zavatti M, Resca E, Carnevale G, Benelli A, Zanoli P, Palumbo C. 2010. Influence of ferutinin on bone metabolism in ovariectomized rats. II: Role in recovering osteoporosis. J Anat, 217: 48-56. Franceschi RT, XiaoG, Jiang D, Gopalakrishnan R, Yang S, Reith E. 2003. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res, 44: 109-116. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P. 2002. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol, 22: 6222-6233. Golub EE, Boesze-Battaglia K. 2007. The role of alkaline phosphatase in mineralization. Curr Opin Orthop, 18: 444-448. Iranshahy M, Iranshahi M. 2011. Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gumresin)—A review. JEthnopharmacol, 134: 1-10. Kim YJ, Lee MH, Wozney JM, ChoJY, Ryoo HM. 2004. Bone morphogenetic protein-2- induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem, 279: 50773-50780. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson R, Gao Y-H, Inada M. 1997. Targeted disruption of Cbfa1results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89: 755-764. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T. 2001. Osteogenic activity of Ferula species AJP, Vol. 11, No. 3, May-Jun 2021 291 Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol, 155: 157-166. Mahmoudi Z, Soleimani M, Saidi A, Iranshahi M, Azizsoltanli A. 2013. Effect of Ferula gummosa ethanolic extract on osteogenesis in human mesenchymal stem cells. J Med Plants, 2: 50-59. Mahmoudi Z, Soleimani M, Saidi A, Khamisipour G, & Azizsoltani A. 2013. Effects of Foeniculum vulgare ethanol extract on osteogenesis in human mecenchymal stem cells. Avicenna J Phytomed, 3: 135-142. Matin M, Nakhaeizadeh H, Bahrami A, Iranshahi M, Arghiani N, Behnam Rassouli F. 2014. Ferutinin, an apoptosis inducing terpenoid from Ferula ovina. Asian Pac J Cancer Prev, 15: 2123-2128. Mirhashemi S, Kalantar Motamedi MH, Mirhashemi AH, Mehrvarz S, Danial Z. 2017. Osteoporosis in Iran. Hosp Pract Res, 2: 57-57. Moazzami Farida SH, Ghorbani A, Ajani Y, Sadr M, Mozaffarian V. 2018. Ethnobotanical applications and their correspondence with phylogeny in Apiaceae-Apioideae. Res J Pharmacognosy, 5: 79-97. Palumbo C, Cavani F, Bertoni L,Ferretti M. 2012. Role of phytoestrogen ferutinin in preventing/recovering bone loss: results from experimental ovariectomized rat models. In: DionyssiotisY(Ed.), Osteoporesis, pp. 711-732, London, IntechOpen. Palumbo C, Ferretti M, Bertoni L, Cavani F, Resca E, Casolari B, Carnevale G, Zavatti M, Montanari C, Benelli A, Zanoli P. 2009. Influence of ferutinin on bone metabolism in ovariectomized rats. I: role in preventing osteoporosis. J Bone Miner Metab, 27: 538- 545. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 30: e36. Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L. (2013). Cell viability assay. Eli Lilly & Company and the National Center for Advancing Translational Sciences. Saeed IA, Ali L, Jabeen A, Khasawneh M, Rizvi TA, AshrafSS. 2012. Estrogenic activities of ten medicinal herbs from the middle east.J Chromatogr Sci, 51: 33-39. Safaeian L, Ghannadi A, Javanmard SH, Vahidian MH. 2015. The effect of hydroalcoholic extract of Ferula foetida stems on blood pressure and oxidative stress in dexamethasone-induced hypertensive rats. Res Pharm Sci, 10: 326- 334. Safi R, Hamade A, Bteich N, El Saghir J, Assaf MD, El-Sabban M et al. 2018. A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro. Biomed Pharmacother, 105: 267-273. Salaminia S, Mohsenzadeh Y, Motedayen M, Sayehmiri F, Dousti M. 2019. Hormone replacement therapy and postmenopausal cardiovascular events: a meta-analysis. Iran Red Crescent Med J, 21: e82298. Zainabadi K, Liu CJ, Guarente L. 2017. SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2. PLOS ONE, 12: e0178520. Zavatti M, Resca E, Bertoni L, Maraldi T, Guida M, Carnevale G, Ferrari A, De Pol A. 2013. Ferutinin promotes proliferation and osteoblastic differentiation in human amniotic fluid and dental pulp stem cells. Life Sci, 92: 993-1003. Zhao Z, Zhao M, Xiao G, Franceschi RT. 2005. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther, 12: 247-253. | ||
آمار تعداد مشاهده مقاله: 9,010 تعداد دریافت فایل اصل مقاله: 1,094 |